Discover why Denali Therapeutics Inc. earns a Strong Buy with FDA-priority drugs, solid pipeline, and a strong cash position. Click for this DNLI stock update.

Earlier this year, Denali Therapeutics completed a US$200,000,000 secondary offering of common shares and pre-funded warrants while engaging with the FDA on a potential priority review voucher linked ...

Denali Therapeutics (DNLI) just wrapped up a $200 million secondary offering, bolstering its cash pile as it continues talks with the FDA over a potential priority review voucher that could speed key ...

Denali National Park and Preserve is named for the nation’s mightiest mountain, but the 6-million-acre park encompasses so much more. Denali has options for every type of visitor. Whether you’re an ...

On December 11, Wedbush analyst Laura Chico maintained her bullish stance on Denali Therapeutics (NASDAQ:DNLI).

Denali, North America's tallest peak, is seen from Parks Highway on Sept. 20, 2022. (Photo by Yereth Rosen/Alaska Beacon) A new plan by President-Elect Donald Trump to undo one of President Barack ...

People stand at the Eielson Visitor Center with a view of North America's tallest peak, Denali (AP Photo/Becky Bohrer, file) Centuries ago, Alaska's native Koyukon people settled on the name "Denali" ...

Carole Ho, MD, is the chief medical officer and head of development at Denali Therapeutics in South San Francisco. A neuroscientist and clinical neurologist by training, she originally planned to be a ...